Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
MedroxyProgesterone market report explains the definition, types, applications, major countries, and major players of the MedroxyProgesterone market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Carlo Erba
Pfizer
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm group
China Resources Zizhu Pharmaceutical
Yantai Luyin Pharmaceutical
Beijing Kangbide Pharmaceutical
Hubei Gedian Renfu Pharmaceutical
Nanjing Chengong Pharmaceutical
GMP
Nanjing Housheng Pharmaceutical
Jiangxi Zezhong Pharmaceutical
Beijing Yimin Pharmaceutical
Harbin Outi Pharmaceutical
Guangzhou Kanghe Pharmaceutical
Chuankang Pharmaceutical
Beijing Langyi Pharmaceutical
Shanghai Xinhualian Pharmaceutical
Hong Kong Aomei Pharmaceutical Factory
Polichem
Guangzhou Langsheng Pharmaceutical
Zhejiang Xianju Pharmaceutical
By Type:
Injection
Tablets
Capsule
Long-Acting Injection (Powder)
Cycloprogesterone Oil Injection
Medroxyprogesterone Silicone Rubber Vaginal Ring
By End-User:
Kidney Cancer
Breast Cancer
Endometrial Cancer
Prostate Cancer
Long-Acting Contraception
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global MedroxyProgesterone Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 MedroxyProgesterone Outlook to 2028- Original Forecasts
-
2.2 MedroxyProgesterone Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term MedroxyProgesterone Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global MedroxyProgesterone Market- Recent Developments
-
6.1 MedroxyProgesterone Market News and Developments
-
6.2 MedroxyProgesterone Market Deals Landscape
7 MedroxyProgesterone Raw Materials and Cost Structure Analysis
-
7.1 MedroxyProgesterone Key Raw Materials
-
7.2 MedroxyProgesterone Price Trend of Key Raw Materials
-
7.3 MedroxyProgesterone Key Suppliers of Raw Materials
-
7.4 MedroxyProgesterone Market Concentration Rate of Raw Materials
-
7.5 MedroxyProgesterone Cost Structure Analysis
-
7.5.1 MedroxyProgesterone Raw Materials Analysis
-
7.5.2 MedroxyProgesterone Labor Cost Analysis
-
7.5.3 MedroxyProgesterone Manufacturing Expenses Analysis
8 Global MedroxyProgesterone Import and Export Analysis (Top 10 Countries)
-
8.1 Global MedroxyProgesterone Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global MedroxyProgesterone Export by Region (Top 10 Countries) (2017-2028)
9 Global MedroxyProgesterone Market Outlook by Types and Applications to 2022
-
9.1 Global MedroxyProgesterone Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Long-Acting Injection (Powder) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Cycloprogesterone Oil Injection Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Medroxyprogesterone Silicone Rubber Vaginal Ring Consumption and Growth Rate (2017-2022)
-
9.2 Global MedroxyProgesterone Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Endometrial Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Long-Acting Contraception Consumption and Growth Rate (2017-2022)
10 Region and Country-wise MedroxyProgesterone Market Analysis and Outlook till 2022
-
10.1 Global MedroxyProgesterone Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States MedroxyProgesterone Consumption (2017-2022)
-
10.2.2 Canada MedroxyProgesterone Consumption (2017-2022)
-
10.2.3 Mexico MedroxyProgesterone Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany MedroxyProgesterone Consumption (2017-2022)
-
10.3.2 UK MedroxyProgesterone Consumption (2017-2022)
-
10.3.3 Spain MedroxyProgesterone Consumption (2017-2022)
-
10.3.4 Belgium MedroxyProgesterone Consumption (2017-2022)
-
10.3.5 France MedroxyProgesterone Consumption (2017-2022)
-
10.3.6 Italy MedroxyProgesterone Consumption (2017-2022)
-
10.3.7 Denmark MedroxyProgesterone Consumption (2017-2022)
-
10.3.8 Finland MedroxyProgesterone Consumption (2017-2022)
-
10.3.9 Norway MedroxyProgesterone Consumption (2017-2022)
-
10.3.10 Sweden MedroxyProgesterone Consumption (2017-2022)
-
10.3.11 Poland MedroxyProgesterone Consumption (2017-2022)
-
10.3.12 Russia MedroxyProgesterone Consumption (2017-2022)
-
10.3.13 Turkey MedroxyProgesterone Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China MedroxyProgesterone Consumption (2017-2022)
-
10.4.2 Japan MedroxyProgesterone Consumption (2017-2022)
-
10.4.3 India MedroxyProgesterone Consumption (2017-2022)
-
10.4.4 South Korea MedroxyProgesterone Consumption (2017-2022)
-
10.4.5 Pakistan MedroxyProgesterone Consumption (2017-2022)
-
10.4.6 Bangladesh MedroxyProgesterone Consumption (2017-2022)
-
10.4.7 Indonesia MedroxyProgesterone Consumption (2017-2022)
-
10.4.8 Thailand MedroxyProgesterone Consumption (2017-2022)
-
10.4.9 Singapore MedroxyProgesterone Consumption (2017-2022)
-
10.4.10 Malaysia MedroxyProgesterone Consumption (2017-2022)
-
10.4.11 Philippines MedroxyProgesterone Consumption (2017-2022)
-
10.4.12 Vietnam MedroxyProgesterone Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil MedroxyProgesterone Consumption (2017-2022)
-
10.5.2 Colombia MedroxyProgesterone Consumption (2017-2022)
-
10.5.3 Chile MedroxyProgesterone Consumption (2017-2022)
-
10.5.4 Argentina MedroxyProgesterone Consumption (2017-2022)
-
10.5.5 Venezuela MedroxyProgesterone Consumption (2017-2022)
-
10.5.6 Peru MedroxyProgesterone Consumption (2017-2022)
-
10.5.7 Puerto Rico MedroxyProgesterone Consumption (2017-2022)
-
10.5.8 Ecuador MedroxyProgesterone Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain MedroxyProgesterone Consumption (2017-2022)
-
10.6.2 Kuwait MedroxyProgesterone Consumption (2017-2022)
-
10.6.3 Oman MedroxyProgesterone Consumption (2017-2022)
-
10.6.4 Qatar MedroxyProgesterone Consumption (2017-2022)
-
10.6.5 Saudi Arabia MedroxyProgesterone Consumption (2017-2022)
-
10.6.6 United Arab Emirates MedroxyProgesterone Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria MedroxyProgesterone Consumption (2017-2022)
-
10.7.2 South Africa MedroxyProgesterone Consumption (2017-2022)
-
10.7.3 Egypt MedroxyProgesterone Consumption (2017-2022)
-
10.7.4 Algeria MedroxyProgesterone Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia MedroxyProgesterone Consumption (2017-2022)
-
10.8.2 New Zealand MedroxyProgesterone Consumption (2017-2022)
11 Global MedroxyProgesterone Competitive Analysis
-
11.1 Carlo Erba
-
11.1.1 Carlo Erba Company Details
-
11.1.2 Carlo Erba MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Carlo Erba MedroxyProgesterone Main Business and Markets Served
-
11.1.4 Carlo Erba MedroxyProgesterone Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer MedroxyProgesterone Main Business and Markets Served
-
11.2.4 Pfizer MedroxyProgesterone Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
-
11.3.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
-
11.3.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Main Business and Markets Served
-
11.3.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sinopharm group
-
11.4.1 Sinopharm group Company Details
-
11.4.2 Sinopharm group MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sinopharm group MedroxyProgesterone Main Business and Markets Served
-
11.4.4 Sinopharm group MedroxyProgesterone Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 China Resources Zizhu Pharmaceutical
-
11.5.1 China Resources Zizhu Pharmaceutical Company Details
-
11.5.2 China Resources Zizhu Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 China Resources Zizhu Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.5.4 China Resources Zizhu Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Yantai Luyin Pharmaceutical
-
11.6.1 Yantai Luyin Pharmaceutical Company Details
-
11.6.2 Yantai Luyin Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Yantai Luyin Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.6.4 Yantai Luyin Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Beijing Kangbide Pharmaceutical
-
11.7.1 Beijing Kangbide Pharmaceutical Company Details
-
11.7.2 Beijing Kangbide Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Beijing Kangbide Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.7.4 Beijing Kangbide Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Hubei Gedian Renfu Pharmaceutical
-
11.8.1 Hubei Gedian Renfu Pharmaceutical Company Details
-
11.8.2 Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.8.4 Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Nanjing Chengong Pharmaceutical
-
11.9.1 Nanjing Chengong Pharmaceutical Company Details
-
11.9.2 Nanjing Chengong Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Nanjing Chengong Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.9.4 Nanjing Chengong Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 GMP
-
11.10.1 GMP Company Details
-
11.10.2 GMP MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 GMP MedroxyProgesterone Main Business and Markets Served
-
11.10.4 GMP MedroxyProgesterone Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Nanjing Housheng Pharmaceutical
-
11.11.1 Nanjing Housheng Pharmaceutical Company Details
-
11.11.2 Nanjing Housheng Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Nanjing Housheng Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.11.4 Nanjing Housheng Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Jiangxi Zezhong Pharmaceutical
-
11.12.1 Jiangxi Zezhong Pharmaceutical Company Details
-
11.12.2 Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.12.4 Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Beijing Yimin Pharmaceutical
-
11.13.1 Beijing Yimin Pharmaceutical Company Details
-
11.13.2 Beijing Yimin Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Beijing Yimin Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.13.4 Beijing Yimin Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Harbin Outi Pharmaceutical
-
11.14.1 Harbin Outi Pharmaceutical Company Details
-
11.14.2 Harbin Outi Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Harbin Outi Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.14.4 Harbin Outi Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Guangzhou Kanghe Pharmaceutical
-
11.15.1 Guangzhou Kanghe Pharmaceutical Company Details
-
11.15.2 Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.15.4 Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Chuankang Pharmaceutical
-
11.16.1 Chuankang Pharmaceutical Company Details
-
11.16.2 Chuankang Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Chuankang Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.16.4 Chuankang Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Beijing Langyi Pharmaceutical
-
11.17.1 Beijing Langyi Pharmaceutical Company Details
-
11.17.2 Beijing Langyi Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Beijing Langyi Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.17.4 Beijing Langyi Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Shanghai Xinhualian Pharmaceutical
-
11.18.1 Shanghai Xinhualian Pharmaceutical Company Details
-
11.18.2 Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.18.4 Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Hong Kong Aomei Pharmaceutical Factory
-
11.19.1 Hong Kong Aomei Pharmaceutical Factory Company Details
-
11.19.2 Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Main Business and Markets Served
-
11.19.4 Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Polichem
-
11.20.1 Polichem Company Details
-
11.20.2 Polichem MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Polichem MedroxyProgesterone Main Business and Markets Served
-
11.20.4 Polichem MedroxyProgesterone Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Guangzhou Langsheng Pharmaceutical
-
11.21.1 Guangzhou Langsheng Pharmaceutical Company Details
-
11.21.2 Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.21.4 Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Zhejiang Xianju Pharmaceutical
-
11.22.1 Zhejiang Xianju Pharmaceutical Company Details
-
11.22.2 Zhejiang Xianju Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Zhejiang Xianju Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
11.22.4 Zhejiang Xianju Pharmaceutical MedroxyProgesterone Product Portfolio
-
11.22.5 Recent Research and Development Strategies
12 Global MedroxyProgesterone Market Outlook by Types and Applications to 2028
-
12.1 Global MedroxyProgesterone Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Long-Acting Injection (Powder) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Cycloprogesterone Oil Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Medroxyprogesterone Silicone Rubber Vaginal Ring Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global MedroxyProgesterone Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Endometrial Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Long-Acting Contraception Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise MedroxyProgesterone Market Analysis and Outlook to 2028
-
13.1 Global MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.2.2 Canada MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.2.3 Mexico MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.2 UK MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.3 Spain MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.4 Belgium MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.5 France MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.6 Italy MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.7 Denmark MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.8 Finland MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.9 Norway MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.10 Sweden MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.11 Poland MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.12 Russia MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.3.13 Turkey MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.2 Japan MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.3 India MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.4 South Korea MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.5 Pakistan MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.7 Indonesia MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.8 Thailand MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.9 Singapore MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.10 Malaysia MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.11 Philippines MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.4.12 Vietnam MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5.2 Colombia MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5.3 Chile MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5.4 Argentina MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5.5 Venezuela MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5.6 Peru MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.5.8 Ecuador MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.6.2 Kuwait MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.6.3 Oman MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.6.4 Qatar MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.7.2 South Africa MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.7.3 Egypt MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.7.4 Algeria MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia MedroxyProgesterone Consumption Forecast (2022-2028)
-
13.8.2 New Zealand MedroxyProgesterone Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of MedroxyProgesterone
-
Figure of MedroxyProgesterone Picture
-
Table Global MedroxyProgesterone Import by Region (Top 10 Countries) (2017-2028)
-
Table Global MedroxyProgesterone Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Long-Acting Injection (Powder) Consumption and Growth Rate (2017-2022)
-
Figure Global Cycloprogesterone Oil Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Medroxyprogesterone Silicone Rubber Vaginal Ring Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Endometrial Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Long-Acting Contraception Consumption and Growth Rate (2017-2022)
-
Figure Global MedroxyProgesterone Consumption by Country (2017-2022)
-
Table North America MedroxyProgesterone Consumption by Country (2017-2022)
-
Figure United States MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Canada MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Mexico MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Table Europe MedroxyProgesterone Consumption by Country (2017-2022)
-
Figure Germany MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure UK MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Spain MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Belgium MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure France MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Italy MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Denmark MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Finland MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Norway MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Sweden MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Poland MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Russia MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Turkey MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Table APAC MedroxyProgesterone Consumption by Country (2017-2022)
-
Figure China MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Japan MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure India MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure South Korea MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Pakistan MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Indonesia MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Thailand MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Singapore MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Malaysia MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Philippines MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Vietnam MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Table South America MedroxyProgesterone Consumption by Country (2017-2022)
-
Figure Brazil MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Colombia MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Chile MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Argentina MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Venezuela MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Peru MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Ecuador MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Table GCC MedroxyProgesterone Consumption by Country (2017-2022)
-
Figure Bahrain MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Kuwait MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Oman MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Qatar MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Table Africa MedroxyProgesterone Consumption by Country (2017-2022)
-
Figure Nigeria MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure South Africa MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Egypt MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure Algeria MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Table Oceania MedroxyProgesterone Consumption by Country (2017-2022)
-
Figure Australia MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Figure New Zealand MedroxyProgesterone Consumption and Growth Rate (2017-2022)
-
Table Carlo Erba Company Details
-
Table Carlo Erba MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Carlo Erba MedroxyProgesterone Main Business and Markets Served
-
Table Carlo Erba MedroxyProgesterone Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer MedroxyProgesterone Main Business and Markets Served
-
Table Pfizer MedroxyProgesterone Product Portfolio
-
Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
-
Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Main Business and Markets Served
-
Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Product Portfolio
-
Table Sinopharm group Company Details
-
Table Sinopharm group MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sinopharm group MedroxyProgesterone Main Business and Markets Served
-
Table Sinopharm group MedroxyProgesterone Product Portfolio
-
Table China Resources Zizhu Pharmaceutical Company Details
-
Table China Resources Zizhu Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Resources Zizhu Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table China Resources Zizhu Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Yantai Luyin Pharmaceutical Company Details
-
Table Yantai Luyin Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yantai Luyin Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Yantai Luyin Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Beijing Kangbide Pharmaceutical Company Details
-
Table Beijing Kangbide Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Kangbide Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Beijing Kangbide Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Hubei Gedian Renfu Pharmaceutical Company Details
-
Table Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Nanjing Chengong Pharmaceutical Company Details
-
Table Nanjing Chengong Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanjing Chengong Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Nanjing Chengong Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table GMP Company Details
-
Table GMP MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table GMP MedroxyProgesterone Main Business and Markets Served
-
Table GMP MedroxyProgesterone Product Portfolio
-
Table Nanjing Housheng Pharmaceutical Company Details
-
Table Nanjing Housheng Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanjing Housheng Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Nanjing Housheng Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Jiangxi Zezhong Pharmaceutical Company Details
-
Table Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Beijing Yimin Pharmaceutical Company Details
-
Table Beijing Yimin Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Yimin Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Beijing Yimin Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Harbin Outi Pharmaceutical Company Details
-
Table Harbin Outi Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Harbin Outi Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Harbin Outi Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Guangzhou Kanghe Pharmaceutical Company Details
-
Table Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Chuankang Pharmaceutical Company Details
-
Table Chuankang Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chuankang Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Chuankang Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Beijing Langyi Pharmaceutical Company Details
-
Table Beijing Langyi Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Langyi Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Beijing Langyi Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Shanghai Xinhualian Pharmaceutical Company Details
-
Table Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Hong Kong Aomei Pharmaceutical Factory Company Details
-
Table Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Main Business and Markets Served
-
Table Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Product Portfolio
-
Table Polichem Company Details
-
Table Polichem MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Polichem MedroxyProgesterone Main Business and Markets Served
-
Table Polichem MedroxyProgesterone Product Portfolio
-
Table Guangzhou Langsheng Pharmaceutical Company Details
-
Table Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Product Portfolio
-
Table Zhejiang Xianju Pharmaceutical Company Details
-
Table Zhejiang Xianju Pharmaceutical MedroxyProgesterone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhejiang Xianju Pharmaceutical MedroxyProgesterone Main Business and Markets Served
-
Table Zhejiang Xianju Pharmaceutical MedroxyProgesterone Product Portfolio
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-Acting Injection (Powder) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cycloprogesterone Oil Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medroxyprogesterone Silicone Rubber Vaginal Ring Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endometrial Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-Acting Contraception Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Table North America MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Figure United States MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Figure Germany MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure France MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Figure China MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure India MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Table South America MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Figure Brazil MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Figure Bahrain MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Figure Nigeria MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania MedroxyProgesterone Consumption Forecast by Country (2022-2028)
-
Figure Australia MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand MedroxyProgesterone Consumption Forecast and Growth Rate (2022-2028)
-
